Proposal of a predictive model for advanced fibrosis containing Wisteria floribunda agglutinin-positive Mac-2-binding protein in chronic hepatitis C

Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B

(2015) M. Houot et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Serum WFA+-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C

(2015) K. Ura et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Wisteria floribundaagglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients

(2015) Nobuharu Tamaki et al.   HEPATOLOGY RESEARCH

Impact of serumWisteria floribundaagglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis

(2015) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Clinical significance of serumWisteria floribundaagglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis

(2015) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma

(2015) Masato Fujiyoshi et al.   JOURNAL OF GASTROENTEROLOGY

Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection

(2015) Hidenori Toyoda et al.   LIVER INTERNATIONAL

Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response

(2015) Ryu Sasaki et al.   PLoS One

Elevated serum levels ofWisteria floribundaagglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

(2014) Kazumi Yamasaki et al.   HEPATOLOGY

Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review

(2014) Yukio Osaki et al.   HEPATOLOGY RESEARCH

A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis

(2014) Takeo Toshima et al.   JOURNAL OF GASTROENTEROLOGY

P465 SVR IS ASSOCIATED WITH NO RISK REDUCTION OF HCC DEVELOPMENT IN PATIENTS WITH HCV-RELATED CIRRHOSIS. A PROSPECTIVE, UP-TO 23 YEARS, COHORT FOLLOW-UP STUDY

(2014) S. Bruno et al.   JOURNAL OF HEPATOLOGY

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

(2013) Adriaan J. van der Meer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis

(2013) Simona Bota et al.   LIVER INTERNATIONAL

Surveillance for hepatocellular carcinoma in chronic liver disease: Evidence and controversies

(2013) Suzanne van Meer   WORLD JOURNAL OF GASTROENTEROLOGY

A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis

(2013) Atsushi Kuno et al.   Scientific Reports

Hepatocellular Carcinoma

(2011) Hashem B. El-Serag   NEW ENGLAND JOURNAL OF MEDICINE

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

(2010) Yasuhiro Asahina et al.   HEPATOLOGY

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis

(2010) Zhong-Hua Lin et al.   HEPATOLOGY

Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?

(2010) Lars Peters et al.   Current Opinion in HIV and AIDS

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

(2009) Gary L. Davis et al.   GASTROENTEROLOGY

Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis

(2008) Mireen Friedrich–Rust et al.   GASTROENTEROLOGY

Non-invasive evaluation of liver fibrosis using transient elastography

(2008) Laurent Castera et al.   JOURNAL OF HEPATOLOGY